Past the pill and product: What do VCs want?
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
During a panel at MedCity INVEST, four experts addressed what VCs and potential acquirers are looking for in emerging companies.
In an outcomes-driven environment, focusing on patients is key but value needs to be demonstrated for all stakeholders when adopting new strategies to go beyond the pill.
Amgen is looking for a senior counsel as part of an expansion of its digital health team. Guess who they contacted?
Neuromodulation is being eyed as one of the beyond-the-pill growth fields of the future. Here are five ways startups are using this technology.